Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
GGN GAMCO Global Gold, Natural Resources & Income Trust
GGN GAMCO Global Gold, Natural Resources & Income Trust
GGGOF Galane Gold Ltd
GFY Western Asset Variable Rate Strategic Fund Inc
GEF Greif Inc
GE General Electric Co
GDXJ VanEck Vectors Junior Gold Miners ETF
GDX VanEck Vectors Gold Miners ETF
GD General Dynamics Corp
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Closing Price
$62.25
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
62.51
Day's Low
61.77
Volume
(Light)
Volume:
7,142,839

10-day average volume:
9,831,062
7,142,839

Moore Kuehn Encourages VSLR, GRAF, BDGE, and MXIM, Investors to Contact Law Firm

1:51 pm ET July 14, 2020 (PR Newswire) Print

Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies:

https://mma.prnewswire.com/media/698123/Moore_Kuehn_Logo.jpg

-- Maxim Integrated Products, Inc. (NASDAQ GS: MXIM)

Maxim has agreed to merge with Analog Devices. Under the terms of the agreement, shareholders of Maxim will receive 0.630 of an Analog share for each share of Maxim they own.

-- Vivint Solar, Inc. (NYSE: VSLR)

Vivint has agreed to merge with Sunrun. Under the terms of the agreement, each share of Vivint Solar will be exchanged for 0.55 shares of Sunrun. Shareholders will be subject to the future price fluctuation of Sunrun's stock price.

-- Graf Industrial Corp. (NYSE: GRAF)

Graf has agreed to merge with Velodyne Lidar. Under the terms of the agreement, Graf will acquire Velodyne through a reverse merger in which Velodyne is ascribed an enterprise value of approximately $1.6 billion and equity value of approximately $1.8 billion.

-- Bridge Bancorp, Inc. (NASDAQ GS: BDGE)

Bridge Bancorp has agreed to merge with Dime Community Bancshare. Under the proposed transaction, shareholders of Bridge will own approximately 48% of the combined company.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.

Moore Kuehn encourages shareholders who would like to discuss their rights to contact Fletcher Moore, Esq. by email at fmoore@moorekuehn.com or telephone at (212) 709-8245. The consultation and case are free with no obligation to you. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Moore Kuehn is a 5-star New York City-based law firm with attorneys representing investors and consumers in class action litigation involving securities law violations, financial fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please go to http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:Moore Kuehn, PLLCFletcher Moore, Esq.30 Wall Street, 8th FloorNew York, New York 10005 fmoore@moorekuehn.com (212) 709-8245

https://c212.net/c/img/favicon.png?sn=NY63134&sd=2020-07-14

View original content to download multimedia:http://www.prnewswire.com/news-releases/moore-kuehn-encourages-vslr-graf-bdge-and-mxim-investors-to-contact-law-firm-301093314.html

SOURCE Moore Kuehn, PLLC

https://rt.prnewswire.com/rt.gif?NewsItemId=NY63134&Transmission_Id=202007141351PR_NEWS_USPR_____NY63134&DateId=20200714

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.